Sawyer & Company’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-207
Closed -$20K 178
2018
Q4
$20K Hold
207
0.01% 145
2018
Q3
$25K Hold
207
0.02% 152
2018
Q2
$23K Hold
207
0.02% 154
2018
Q1
$22K Hold
207
0.01% 156
2017
Q4
$22K Buy
+207
New +$22.1K 0.01% 143

Other funds holding IBB

Sawyer & Company's IBB Position: Q1 2019 in Review

Sawyer & Company sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 207 shares — an estimated $20K sold.

Sawyer & Company first reported a position in IBB in Q4 2017 and held it in 5 quarters. The position peaked at $25K in Q3 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

  • Sawyer & Company reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
  • Sawyer & Company sold 207 iShares Biotechnology ETF shares in Q1 2019, an estimated $20K.
  • Sawyer & Company first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 5 quarters.
  • Sawyer & Company's iShares Biotechnology ETF position peaked at $25K in Q3 2018.
  • 670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Sawyer & Company's 13F filing for Q1 2019, filed 6 May 2019.